Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Feb 15, 2023; 15(2): 352-367
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.352
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.352
Figure 1 The action mechanism of programmed cell death receptor-1, programmed death receptor-ligand 1, and cytotoxic T lymphocyte-associated antigen-4 inhibitors.
PD-1: Programmed cell death receptor-1; PD-L1: Programmed death receptor-ligand 1; CTLA-4: Cytotoxic T lymphocyte-associated antigen-4; TCR: T-cell receptor; MHC: Major histocompatibility complex; APC: Antigen-presenting cell.
- Citation: Pei WG, Chen WZ, Wu YK, Tan SX, Jie ZG. Immune-related adverse events associated with immune checkpoint inhibitors for advanced gastric and gastroesophageal junction cancer: A meta-analysis. World J Gastrointest Oncol 2023; 15(2): 352-367
- URL: https://www.wjgnet.com/1948-5204/full/v15/i2/352.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i2.352